[1] AMJAD A I, PAL I. De novo primary squamous cell carcinoma of the ovary: a case of a rare malignancy with an aggressive clinical course[J]. J Pak Med Assoc, 2008, 58(5):272-274.
[2] PINS M R, YOUNG R H, DALY W J, et al. Primary squamous cell carcinoma of the ovary. Report of 37 cases[J]. Am J Surg Pathol, 1996, 20(7):823-833.
[3] LI C, ZHANG Q, ZHANG S, et al. Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review[J]. BMC Cancer, 2019, 19(1):217.
[4] PARK J Y, SONG J S, CHOI G, et al. Pure primary squamous cell carcinoma of the ovary: a report of two cases and review of the literature[J]. Int J Gynecol Pathol, 2010, 29(4):328-334.
[5] SHIMADA M, KIGAWA J, NISHIMURA R, et al. Ovarian metastasis in carcinoma of the uterine cervix[J]. Gynecol Oncol, 2006, 101(2):234-237.
[6] KOUFOPOULOS N, NASI D, GOUDELI C, et al. Primary squamous cell carcinoma of the ovary. Review of the literature[J]. J BUON, 2019, 24(5):1776-1784.
[7] MCGRADY B J, SLOAN J M, LAMKI H, et al. Bilateral ovarian cysts with squamous intraepithelial neoplasia[J]. Int J Gynecol Pathol, 1993, 12(4):350-354.
[8] SWORN M J, JONES H, LETCHWORTH A T, et al. Squamous intraepithelial neoplasia in an ovarian cyst, cervical intraepithelial neoplasia, and human papillomavirus[J]. Hum Pathol, 1995, 26(3):344-347.
[9] MAI K T, YAZDI H M, BERTRAND M A, et al. Bilateral primary ovarian squamous cell carcinoma associated with human papilloma virus infection and vulvar and cervical intraepithelial neoplasia. A case report with review of the literature[J]. Am J Surg Pathol, 1996, 20(6):767-772.
[10] ROXBURGH P, GLASSPOOL R. Squamous carcinoma of the ovary[J]. Curr Oncol Rep, 2014, 16(12):413.
[11] IWASA A, ODA Y, KURIHARA S, et al. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins[J]. Pathol Int, 2008, 58(12):757-764.
[12] BLACK W C, BENITEZ R E. Nonteratomatous squamous-cell carcinoma in situ of the ovary[J]. Obstet Gynecol, 1964, 24:865-868.
[13] MACKO M B, JOHNSON L A. Primary squamous ovarian carcinoma. A case report and review of the literature[J]. Cancer, 1983, 52(6):1117-1119.
[14] CHEN K T. Squamous cell carcinoma of the ovary[J]. Arch Pathol Lab Med, 1988, 112(2):114-115.
[15] BEN-BARUCH G, MENASHE Y, HERCZEG E, et al. Pure primary ovarian squamous cell carcinoma[J]. Gynecol Oncol, 1988, 29(2):257-262.
[16] YETMAN T J, DUDZINSKI M R. Primary squamous carcinoma of the ovary: a case report and review of the literature[J]. Gynecol Oncol, 1989, 34(2):240-243.
[17] KASHIMURA M, SHINOHARA M, HIRAKAWA T, et al. Clinicopathologic study of squamous cell carcinoma of the ovary[J]. Gynecol Oncol, 1989, 34(1):75-79.
[18] RADHI J M, AWAD S M. Bilateral squamous cell carcinoma of the ovary. Case report[J]. Br J Obstet Gynaecol, 1990, 97(9):855-856.
[19] SHIMAMATSU K, IEMURA A, NAKASHIMA O, et al. Squamous cell carcinoma of the ovary[J]. Kurume Med J, 1994, 41(4):177-182.
[20] KHANFAR N M, ARNDT C A, WOLD L E. Squamous cell carcinoma in the ovary of a 14-year-old girl[J]. Mayo Clin Proc, 1996, 71(4):380-383.
[21] BALAT O, AYDIN A, CAMCI C, et al. Bilateral primary squamous cell carcinoma of the ovary: a case report of isolated metastasis to the lateral pelvic wall[J]. Eur J Gynaecol Oncol, 2001, 22(6):445-446.
[22] CHIEN S C, SHEU B C, CHANG W C, et al. Pure primary squamous cell carcinoma of the ovary: a case report and review of the literature[J]. Acta Obstet Gynecol Scand, 2005, 84(7):706-708.
[23] NAKAMURA Y, KAMEI T, SHINAGAWA M, et al. Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan[J]. J Obstet Gynaecol Res, 2015, 41(5):809-812.
[24] PARK J W, BAE J W. Pure primary ovarian squamous cell carcinoma: a case report and review of the literature[J]. Oncol Lett, 2015, 9(1):321-323.
[25] SHARMA S, AHLUWALIA C, ZAHEER S, et al. An aggressive rare entity - pure (de novo) primary squamous cell carcinoma of ovary: review of literature and a case report[J]. Clin Cancer Investig, 2015, 4(5):682-686.
[26] SRIVASTAVA H, SHREE S, GULERIA K, et al. Pure primary squamous cell carcinoma of ovary - a rare case report[J]. J Clin Diagn Res, 2017, 11(5):QD01-QD02.
[27] MIMURA K, OKADA A, HARAGUCHI N, et al. Pure primary ovarian squamous cell carcinoma perforating the rectum[J]. Case Rep Obstet Gynecol, 2017, 2017: 9793086.
[28] ABID Z, FATIMA M, ZEHRA D, et al. Primary squamous cell carcinoma of the ovary[J]. Cureus, 2019, 11(10):e5884.
[29] 王毅军, 史慧薇, 赵玲军. 原发性卵巢鳞癌1例报告[C].浙江省妇产科医师大会及妇产科学学术年会论文汇编,[出版地不详]:[出版者不详],2019: 220-222.
[30] 杨祎彬, 杨悦, 孙文勇, 等. 原发性卵巢鳞癌和卵巢成熟畸胎瘤鳞癌变的临床病理分析[J]. 中华妇产科杂志, 2020, 55(7):483-486.
[31] CHEN R J, CHEN K Y, CHANG T C, et al. Prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary[J]. J Formos Med Assoc, 2008, 107(11):857-868.
[32] SUZUKI M, TAMURA N, KOBAYASHI H, et al. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary[J]. Gynecol Oncol, 2000, 77(3):405-409.
[33] FUKASE M, OHTA T, WATANABE N, et al. Squamous cell carcinoma arising from a mature cystic teratoma of the ovary: successful treatment with carboplatin, paclitaxel, and bevacizumab[J]. Gynecol Oncol Rep, 2020, 34:100632.
[34] WU M, BENNETT J A, REID P, et al. Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab[J]. Gynecol Oncol Rep, 2021, 37:100837.
[35] ZHENG H C. The molecular mechanisms of chemoresistance in cancers[J]. Oncotarget, 2017, 8(35):59950-59964.
[36] ASCHAUER L, MULLER P A. Novel targets and interaction partners of mutant p53 gain-of-function[J]. Biochem Soc Trans, 2016, 44(2):460-466.
[37] PRASAD S, RAMACHANDRAN S, GUPTA N, et al. Cancer cells stemness: a doorstep to targeted therapy[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(4):165424.
[38] DENG J, WANG L, CHEN H, et al. Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer[J]. Oncotarget, 2016, 7(34):55771-55788.
[39] COOKE S L, ENNIS D, EVERS L, et al. The driver mutational landscape of ovarian squamous cell carcinomas arising in mature cystic teratoma[J]. Clin Cancer Res, 2017, 23(24):7633-7640. |
